Advanced Oncotherapy (AVO)

 

AVO Share PerformanceMore

52 week high175.000 14/07/16
52 week low13.500 23/06/17
52 week change -123.510 (-89.83%)
4 week volume8,030,985 03/06/17

Media for (AVO)

Presenter: Donatella Ungaro
15/12/2016
Presenter: Nicolas Serandour
13/10/2016

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Final Results

RNS Number: 0808J Advanced Oncotherapy PLC 26 June 2017 ADVANCED ONCOTHERAPY PLC ("Advanced Oncotherapy" or the "Company") Final Results for the year ended 31 December 2016 Advanced Oncotherapy (AIM: AVO), the developer of next generation proton therapy systems for cancer treatment, announces audited results for the year ended 31 De...

Conversion of Convertible Loan Notes

RNS Number: 6618I Advanced Oncotherapy PLC 21 June 2017 ADVANCED ONCOTHERAPY PLC ("Advanced Oncotherapy" or the "Company") Conversion of Convertible Loan Notes Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that Bracknor Investment Group ("Bracknor") has a...

Advanced Oncotherapy appoints senior VP of medical physics

Advanced Oncotherapy, the developer of next-generation proton therapy systems for cancer treatment, has appointed Dr. J...

Appointment of Senior VP of Medical Physics

RNS Number: 0043I Advanced Oncotherapy PLC 14 June 2017 ADVANCED ONCOTHERAPY PLC ("Advanced Oncotherapy" or the "Company") Appointment of Senior Vice-President of Medical Physics Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces the appointment of Dr. Jonathan...

Additional financing agreement and new appointment

RNS Number: 8764H Advanced Oncotherapy PLC 13 June 2017 ADVANCED ONCOTHERAPY PLC ("Advanced Oncotherapy" or the "Company") Additional financing agreement and new appointment Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces it has made further progress in att...

Advanced Oncotherapy update on milestones

Advanced Oncotherapy, the developer of next-generation proton therapy systems for cancer treatment, has announced fur...

Technological milestones update

RNS Number: 7433H Advanced Oncotherapy PLC 12 June 2017 ADVANCED ONCOTHERAPY PLC ("Advanced Oncotherapy" or the "Company") Technological milestones update Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces further notable progress in the manufacture of its first L...

Update on Bracknor financing

RNS Number: 1774H Advanced Oncotherapy PLC 05 June 2017 ADVANCED ONCOTHERAPY PLC ("Advanced Oncotherapy" or the "Company") Update on Bracknor financing - Waiving of requirement to hold a General Meeting Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that f...

Fundamental DataMore

EPS-17.01
Dividend yield0 %

Equity Research (AVO)

hardman & co
Advanced Oncotherapy Plc
15/03/2017
AVO is focused on delivering a more affordable, novel, proton-based radiotherapy system, based on technology originally developed at the world renowned CERN. The company is entering an exciting stage...
Advanced Oncotherapy Plc
27/02/2017
PowerHouse Energy Group (PHE.L) 1p £8.94m PowerHouse has agreed with University of Chester to deploy its G3-UHt unit (ultra-high temperature demonstration gasification system)  at its Thornton...
hardman & co
Advanced Oncotherapy Plc
02/11/2016
AVO is focused on delivering a more affordable, novel proton-based radiotherapy system, based on a technology originally developed and tested at the world renowned CERN. Planning Permission for its...

Latest discussion posts More

  • Re: Once upon a time...

    The management are spending quicker than Bracknor can convert. See what the AGM brings on 19th July, but if it doesn't change it nominal value very soon the receivers will be ...
    26-Jun-2017
    spankaroo
  • Once upon a time...

    I had the chance to sell these for 115% profit. Can't see a recovery now.
    22-Jun-2017
    charlesweeb
  • Re: Whats going on?

    UCLH operational in 2020. Newport operational 'within a year'. I guess these are both using proven cyclotron or synchrotron technology. AVO timescales depending on progress ...
    7-Jun-2017
    marcher

Users' HoldingsMore

Users who hold Advanced Oncotherapy also hold..
LLOYDS GRP.22%
SIRIUS MINERALS13%
TESCO12%
ROYAL BANK SCOT12%
BT GROUP11%

Codes & Symbols

ISINGB00BD6SX109
SymbolsAVO, LSE:AVO, AVO.L, AVO:LN, LON:AVO, XLON:AVO